Checking in on the post-Chevron fallout

Checking in on the post-Chevron fallout

What’s happened in the world of federal regulation since the Supreme Court overturned the decades-old Chevron doctrine in its Loper Bright decision? FDA Law Blog takes a look in “As Jurisprudence Under Loper Bright Develops, Early Scorecard is Mixed.”

Related posts

At least three issues affecting pharmacy compounding might be affected by the overturning of the...

Sterile compounders: Check your ingredients FDA issued a reminder this week to only produce sterile...

FDA tirzepatide ‘reconsideration’ period extended Yesterday, on the deadline FDA was to report back...